Help us improve your experience. Please confirm your investor type:
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
NASDAQ Biotechnology Index (NBI)
The NASDAQ Biotechnology index (NBI) is a sector-focused index. It measures the performance of more than 200 biotechnology and pharmaceuticals stocks listed on the NASDAQ Stock Exchange.
The NASDAQ Biotechnology index is not diversified in terms of sectors. All its components are in the Health Care sector.
Key metrics of the NASDAQ Biotechnology Index
ETFs tracking the NASDAQ Biotechnology Index
BTEC iShares Nasdaq US Biotechnology UCITS ETF - USD This ETF provides exposure to US Equities Share class Acc USD | -3.36% | +0.21% | -€7M | +€36M | €766M | 0.35% |  | |
|---|---|---|---|---|---|---|---|---|
-1.90% | +0.69% | -€4.8M | -€9.7M | €362M | 0.4% |  | ||
BIB ProShares Ultra Nasdaq Biotechnology ETF - USD This ETF provides leveraged exposure (2x) to US Equities | -7.24% | -1.42% | -€2.2M | -€2.2M | €70M | 1.19% | Not rated | |
-3.33% | +0.27% | €0 | +€6.8M | €62M | 0.19% | Not rated | | |
+1.98% | +4.39% | -€1.1M | -€2.3M | €61M | 0.3% | Not rated | | |
BTEE iShares Nasdaq US Biotechnology UCITS ETF (D) - USD This ETF provides exposure to US Equities Share class Dist USD | -3.37% | +0.21% | +€1.4M | +€2.4M | €47M | 0.35% | | |
+0.59% | +4.25% | -€494K | -€16K | €7.8M | 1.01% | Not rated | | |
BIS ProShares UltraShort NASDAQ Biotechnology ETF - USD This ETF provides inverse exposure (-2x) to US Equities | +6.82% | -1.28% | €0 | +€2.6K | €2.3M | 3.2% | Not rated | |
Frequently asked questions about NASDAQ Biotechnology Index
What are some other indices for ETFs similar to the NASDAQ Biotechnology Index?
Other popular NASDAQ indexes include the NASDAQ 100 comprising the 100 largest companies listed on the NASDAQ, the NASDAQ Q-50 which measures the performance of the next 50 largest companies in line to enter the NASDAQ-100, or the NASDAQ-500 which tracks the performance of the 500 largest non-financial companies listed on the NASDAQ stock exchange.
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
